Skip to main content
Fig. 1 | Genome Medicine

Fig. 1

From: High-resolution temporal profiling of the human gut microbiome reveals consistent and cascading alterations in response to dietary glycans

Fig. 1

Effects of FOS and PDX on the human gut microbiome. Cohorts 3 for FOS and PDX received the highest doses of the compounds, cohorts 2 intermediate doses, and cohorts 1 the lowest doses. a Percent changes in alpha (Shannon) diversity between baseline and later periods (feeding1, feeding2, and washout) in each cohort receiving FOS or PDX. b Within-participant Bray Curtis dissimilarity from baseline samples in each cohort receiving either FOS or PDX. c Multidimensional scaling analysis of each participant in the high-dose cohorts receiving either FOS or PDX. Each dot represents the microbiome as measured in a fecal sample from a participant and is colored by study period. d Genera differentially abundant between baseline and feeding periods in each cohort receiving FOS or PDX. The boxplot summarizes taxa shifts across participants and is colored by significance level

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us